2010;24:413 7. 1033. Deleted in proof. 1034. Deleted in proof. 1035. Deleted in proof. 1036. Daoud EG, Strickberger SA, Man KC, et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med. 1997;337:1785 91. 1037. Williams DB, Misbach GA, Kruse AP, et al. Oral verapamil for prophylaxis of supraventricular tachycardia after myocardial revascu- larization. A randomized trial. J Thorac Cardiovasc Surg. 1985;90: 592 6. 1038. Davison R, Hartz R, Kaplan K, et al. Prophylaxis of supraventricular tachyarrhythmia after coronary bypass surgery with oral verapamil: a randomized, double-blind trial. Ann Thorac Surg. 1985;39:336 9. 1039. Tyras DH, Stothert JC Jr, Kaiser GC, et al. Supraventricular tachyarrhythmias after myocardial revascularization: a randomized trial of prophylactic digitalization. J Thorac Cardiovasc Surg. 1979;77: 310 4. 1040. Weiner B, Rheinlander HF, Decker EL, et al. Digoxin prophylaxis following coronary artery bypass surgery. Clin Pharm. 1986;5:55 8. 1041. Johnson LW, Dickstein RA, Fruehan CT, et al. Prophylactic digitali- zation for coronary artery bypass surgery. Circulation. 1976;53: 819 22. 1042. Rahimi K, Emberson J, McGale P, et al. Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. BMJ. 2011;342:d1250. 1043. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/ AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Founda- tion/American Heart Association Task Force on practice guidelines. Circulation. 2011;123:e269 367. 1044. Fergusson DA, Hebert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery [published correction appears in N Engl J Med. 2010;363:1290]. N Engl J Med. 2008;358: 2319 31. 1045. Greilich PE, Jessen ME, Satyanarayana N, et al. 